DVT & Pulmonary Embolism
News
FDA approves cangrelor, an intravenous antiplatelet drug
Conference Coverage
Think ESUS, not cryptogenic stroke
News
Frozen RBCs match fresh in safety, effectiveness
Key clinical point: Cryopreserved red blood cells were as safe and effective to use for trauma transfusions as were fresh red blood cells. Major...
News
Simplified PESI identified low-risk pulmonary embolism
Key clinical point: The simplified version of the PESI identified low-risk pulmonary embolism patients. Major finding: Patients with scores of 0...
News
Low-risk PE patients can be treated as outpatients
News
Fondaparinux safe for VTE prophylaxis in ischemic stroke
News
Extended anticoagulant therapy reduced risk of VTE recurrence
News
Rapid INR reversal key in oral anticoagulant–associated intracerebral hemorrhage
Key clinical point: Rapid INR reversal and systolic blood pressure reduction in patients lowers the rates of hematoma enlargement and in-hospital...
Government and Regulations
Edoxaban approved for atrial fib, DVT, and PE indications
News
Most acute VTE therapies yield similar outcomes
Key clinical point: Seven of the eight available VTE therapies are equally safe and effective.* Major finding: Compared with standard parenteral...
Conference Coverage
Ultrasound-facilitated endovascular thrombolysis 'a game changer' in acute pulmonary embolism
Major finding: Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in patients with high-risk pulmonary embolism improved right...